# EDGAR Filing Document

**Accession Number:** 0000831114
**File Stem:** 0000894189-25-012622
**Filing Date:** 2025-10
**Character Count:** 16540
**Document Hash:** 35c132eea1f87056d053a1d87df69418
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000894189-25-012622.hdr.sgml**: 20251029

**ACCESSION NUMBER**: 0000894189-25-012622

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250831

**FILED AS OF DATE**: 20251029

**DATE AS OF CHANGE**: 20251029

**PERIOD START**: 20250831

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RBB FUND, INC.
- **CENTRAL INDEX KEY:** 0000831114

**ORGANIZATION NAME:**
- **EIN:** 510312196
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 0831

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-05518
- **FILM NUMBER:** 251429050

**BUSINESS ADDRESS:**
- **STREET 1:** 615 E. MICHIGAN ST.
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202
- **BUSINESS PHONE:** 609-731-6256

**MAIL ADDRESS:**
- **STREET 1:** 615 E. MICHIGAN ST.
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** RBB FUND INC
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FUND INC /DE/
- **DATE OF NAME CHANGE:** 19600201

## Series and Classes Contracts Data

### F/m Emerald Life Sciences Innovation ETF (Series ID: S000088167)

| Class ID   | Class Name                               | Ticker Symbol   |
|:---|:---|:---|
| C000254221 | F/m Emerald Life Sciences Innovation ETF | LFSC            |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** RBB Fund, Inc.

- **b. Investment Company Act file number:** 811-05518

- **c. CIK number of Registrant:** 0000831114

- **d. LEI of Registrant:** 5493005KKD0GVHSW0D29

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 615 East Michigan Street

  - **City:** Milwaukee

  - **State:** WI

  - **Foreign country:** US

  - **Zip / Postal Code:** 53202

  - **Telephone number:** 262-378-6278

**Item A.2. Information about the Series.**

- **a. Name of Series:** F/m Emerald Life Sciences Innovation ETF

- **b. EDGAR series identifier (if any):** S000088167

- **c. LEI of Series:** 5299004NK8PYE4SUB575

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-08-31

- **b. Date as of which information is reported:** 2025-08-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $64886092.28

**Total Liabilities:** $305105.99

**Net Assets:** $64580986.29

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000254221 | 7.31%                | -1.39%               | 15.06%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $4074634.37              | $-342406.95                                |
| Month 2  | $1220957.76              | $-1983478.42                               |
| Month 3  | $2034427.85              | $6433617.00                                |

**Designated Index Information**

- **Index Name:** N/A

- **Index Identifier:** N/A

### Schedule of Portfolio Investments

| Name                                   | Title                                                         | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Corcept Therapeutics Inc               | Corcept Therapeutics Inc                                      | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |     29449 | NS      | $2053184.28   | 3.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                             | Insmed Inc                                                    | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |     10973 | NS      | $1493425.30   | 2.31%             |  |  |  | No            |                  1 | On Loan: No      |
| F/m Ultrashort Treasury Inflat         | F/m Ultrashort Treasury Inflation-Protected Security TIPS ETF | CUSIP: 74933W213<br>LEI: 5299000J5VH6XTHXW407 | Long             | EC               | RF                | US        |     16539 | NS      | $829265.46    | 1.28%             |  |  |  | No            |                  1 | On Loan: No      |
| TransMedics Group Inc                  | TransMedics Group Inc                                         | CUSIP: 89377M109<br>LEI: 549300060GVOSMWARH50 | Long             | EC               | CORP              | US        |     28006 | NS      | $3219569.76   | 4.99%             |  |  |  | No            |                  1 | On Loan: No      |
| ACADIA Pharmaceuticals Inc             | ACADIA Pharmaceuticals Inc                                    | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |     50159 | NS      | $1303632.41   | 2.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Alphatec Holdings Inc                  | Alphatec Holdings Inc                                         | CUSIP: 02081G201<br>LEI: 549300EZE8CQ8K65FS24 | Long             | EC               | CORP              | US        |    125647 | NS      | $1997787.30   | 3.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences Inc                 | Cogent Biosciences Inc                                        | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    153795 | NS      | $1857843.60   | 2.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Collegium Pharmaceutical Inc           | Collegium Pharmaceutical Inc                                  | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |     53588 | NS      | $2079214.40   | 3.22%             |  |  |  | No            |                  1 | On Loan: No      |
| ICU Medical Inc                        | ICU Medical Inc                                               | CUSIP: 44930G107<br>LEI: 5493003NRW7LS2QZRH60 | Long             | EC               | CORP              | US        |      6396 | NS      | $816513.36    | 1.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Mirum Pharmaceuticals Inc              | Mirum Pharmaceuticals Inc                                     | CUSIP: 604749101<br>LEI: 254900YZKR40F7F27K81 | Long             | EC               | CORP              | US        |     29556 | NS      | $2183301.72   | 3.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Orthofix Medical Inc                   | Orthofix Medical Inc                                          | CUSIP: 68752M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     65777 | NS      | $985339.46    | 1.53%             |  |  |  | No            |                  1 | On Loan: No      |
| RadNet Inc                             | RadNet Inc                                                    | CUSIP: 750491102<br>LEI: 529900RECG94V2IZJ970 | Long             | EC               | CORP              | US        |     45645 | NS      | $3275485.20   | 5.07%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp               | United Therapeutics Corp                                      | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |      2668 | NS      | $813099.68    | 1.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Bridgebio Pharma Inc                   | Bridgebio Pharma Inc                                          | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |     48892 | NS      | $2530649.92   | 3.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                    | Guardant Health Inc                                           | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |     40491 | NS      | $2729903.22   | 4.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Korro Bio Inc                          | Korro Bio Inc                                                 | CUSIP: 500946108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     54817 | NS      | $1265176.36   | 1.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd                           | Biohaven Ltd                                                  | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | US        |     22295 | NS      | $343120.05    | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Merit Medical Systems Inc              | Merit Medical Systems Inc                                     | CUSIP: 589889104<br>LEI: 549300OYTY138SP2CE83 | Long             | EC               | CORP              | US        |     29021 | NS      | $2627561.34   | 4.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Nektar Therapeutics                    | Nektar Therapeutics                                           | CUSIP: 640268306<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |     52699 | NS      | $1573592.14   | 2.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceutical Inc          | Ultragenyx Pharmaceutical Inc                                 | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |     61231 | NS      | $1834480.76   | 2.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Novocure Ltd                           | Novocure Ltd                                                  | CUSIP: N/A<br>LEI: 213800YPP55UMHWA4826       | Long             | EC               | CORP              | JE        |     19015 | NS      | $234454.95    | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Globus Medical Inc                     | Globus Medical Inc                                            | CUSIP: 379577208<br>LEI: 5299003M2P4CIK0RF205 | Long             | EC               | CORP              | US        |     14143 | NS      | $866541.61    | 1.34%             |  |  |  | No            |                  1 | On Loan: No      |
| KalVista Pharmaceuticals Inc           | KalVista Pharmaceuticals Inc                                  | CUSIP: 483497103<br>LEI: 529900Q7IDA3WUGRZA51 | Long             | EC               | CORP              | US        |    197561 | NS      | $2659171.06   | 4.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Savara Inc                             | Savara Inc                                                    | CUSIP: 805111101<br>LEI: 5493002JO0WM3YMJXG33 | Long             | EC               | CORP              | US        |    325797 | NS      | $1068614.16   | 1.65%             |  |  |  | No            |                  1 | On Loan: No      |
| U.S. Bank Money Market Deposit Account | U.S. Bank Money Market Deposit Account                        | CUSIP: 8AMMF0A92<br>LEI: N/A                  | Long             | STIV             | RF                | US        |        60 | NS      | $60.42        | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Spyre Therapeutics Inc                 | Spyre Therapeutics Inc                                        | CUSIP: 00773J202<br>LEI: 52990017AIJPRH3HQH40 | Long             | EC               | CORP              | US        |     54433 | NS      | $897600.17    | 1.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Ceribell Inc                           | Ceribell Inc                                                  | CUSIP: 15678C102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     76899 | NS      | $909715.17    | 1.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Travere Therapeutics Inc               | Travere Therapeutics Inc                                      | CUSIP: 89422G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    194431 | NS      | $3402542.50   | 5.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Akero Therapeutics Inc                 | Akero Therapeutics Inc                                        | CUSIP: 00973Y108<br>LEI: 549300SI3KG74LBE2955 | Long             | EC               | CORP              | US        |      6523 | NS      | $304819.79    | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics Inc                | Axsome Therapeutics Inc                                       | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |     11082 | NS      | $1344024.96   | 2.08%             |  |  |  | No            |                  1 | On Loan: No      |
| 89bio Inc                              | 89bio Inc                                                     | CUSIP: 282559103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    225515 | NS      | $2036400.45   | 3.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Integer Holdings Corp                  | Integer Holdings Corp                                         | CUSIP: 45826H109<br>LEI: 549300SUD2ED5XG6X569 | Long             | EC               | CORP              | US        |     11112 | NS      | $1198651.44   | 1.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Madrigal Pharmaceuticals Inc           | Madrigal Pharmaceuticals Inc                                  | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |      6270 | NS      | $2745319.50   | 4.25%             |  |  |  | No            |                  1 | On Loan: No      |
| LivaNova PLC                           | LivaNova PLC                                                  | CUSIP: N/A<br>LEI: 2138001K2FX6SHK2B339       | Long             | EC               | CORP              | GB        |     77266 | NS      | $4355484.42   | 6.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Soleno Therapeutics Inc                | Soleno Therapeutics Inc                                       | CUSIP: 834203309<br>LEI: 5493003LCY77N7FXK844 | Long             | EC               | CORP              | US        |     55306 | NS      | $3742557.02   | 5.80%             |  |  |  | No            |                  1 | On Loan: No      |
| WaVe Life Sciences Ltd                 | WaVe Life Sciences Ltd                                        | CUSIP: N/A<br>LEI: 54930070006GPKFYZ813       | Long             | EC               | CORP              | US        |    315432 | NS      | $3028147.20   | 4.69%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-10-21

**Name of Applicant:** RBB Fund, Inc.

**Signature:** /s/ James G. Shaw

**Name of Signer:** RBB Fund, Inc.

**Title:** CFO COO Secretary